Biohaven Pharmaceutical Stock Price - BHVN

67.41
0.00 (0.0%)
67.41
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Biohaven Pharmaceutical Holding Company Ltd BHVN NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
1.13 1.7% 67.41 65.372 69.36 65.69 66.28 16:00:04
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
9,139 961,033 $ 67.43 $ 64,803,853 805,541 26.56 - 69.36
Last Trade Time Type Quantity Stock Price Currency
17:49:57 formt 136 $ 67.41 USD

Biohaven Pharmaceutical Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.95B 58.53M 53.07M $ - $ - -10.99 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
10.57M $ - 0.00% - -

more financials information »

Biohaven Pharmaceutical News

Date Time Source News Article
6/02/202009:04Edgar (US Regulatory)Current Report Filing (8-k)
5/19/202016:34Edgar (US Regulatory)Current Report Filing (8-k)
5/18/202007:30PR Newswire (US)Biohaven Showcases Clinical and Pharmacoeconomic Data for..
5/07/202017:20Edgar (US Regulatory)Quarterly Report (10-q)
5/07/202017:11Edgar (US Regulatory)Current Report Filing (8-k)
5/07/202016:10PR Newswire (US)Biohaven Pharmaceuticals Reports First Quarter 2020..
4/30/202017:26Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BHVN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week60.4369.3657.1164.03795,4976.9811.55%
1 Month49.5269.3642.7455.52786,89017.8936.13%
3 Months36.8269.3626.5641.33949,71730.5983.08%
6 Months53.9269.3626.5645.98938,88413.4925.02%
1 Year56.1169.3626.5645.54887,94611.3020.14%
3 Years24.5669.3616.500141.47558,54142.85174.47%
5 Years20.0069.3616.500141.03555,08047.41237.05%

Biohaven Pharmaceutical Description

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.
Your Recent History
NYSE
BHVN
Biohaven P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200604 22:19:24